What changed for market while you were sleeping

Share markets idled in Asia on Monday as investors braced for a week littered with 13 central bank meetings that are certain to see borrowing costs rise across the globe and some risk of a super-sized hike in the United States. MSCI’s index of Asia-Pacific shares outside Japan was trading 0.29 per cent lower.

Time to invest in pharma funds for a contrarian play?

In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.

Nifty could slip to 17,300 as Fed moves in focus: Analysts

The most crucial event in the forthcoming week is the US Fed meeting outcome on September 21, ahead of which global markets are expected to witness heightened volatility. Hence, traders are advised to take hedged bets with appropriate position sizing, keeping leverage in check.

IBC changes to hasten, maximise recovery

In separate notifications over the weekend, IBBI allowed creditors to sell part assets in case they get more value. More importantly, the regulator also announced a performance-based pay structure for resolution professionals (RPs). Both moves will have far-reaching changes to recoveries, consultants said.

South Indian Bank to push retail pedal to growth

South Indian Bank was beset with bad loans after its loans to companies such as DHFL and IL&FS soured. Under Ramakrishnan who took charge about two years ago, the bank raised its provisioning and put in place processes that improved underwriting.

Inox GFL targets zero debt by fiscal end

Inox Wind has recently announced an initial public offering for Inox Green Energy Services (IGESL), which is expected to hit the primary market next month. The IGESL IPO comprises fresh issuance of equity shares worth ₹370 crore and an offer for sale of ₹370 crore by promoter Inox Wind.